The lack of guideline-concordant care for early-stage non-small cell lung cancer may affect the interpretation of adjuvant trial results, according to researchers.
Researchers sought to determine if offering financial reimbursement with or without a follow-up phone call would improve the diversity of patients participating in clinical trials.
A qualitative descriptive study identified the interest and willingness to participate in clinical trials of patients 65 and older and their caregivers.
A structured interview study sought to understand patient experiences after being withdrawn from a cancer clinical trial.
The genomic-adjusted radiation dose (GARD) model predicts outcomes of radiotherapy.